DTC Ad Comparative Claims Draw FDA Criticism, Even With “Scientific Basis”
This article was originally published in The Pink Sheet Daily
Executive Summary
“We’re not pleased with the way direct-to-consumer advertising is going,” Acting Commissioner Crawford says. DTC ads have become “ridiculous,” he says; “very strong measures” by FDA may be warranted.